Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedApr 16, 2025
DataAggregated Company Financials
Companies20
  • 7D-1.3%
  • 3M-27.5%
  • 1Y-47.1%
  • YTD-30.6%

Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by Novo Nordisk declining 1.9%. However, the industry is down 47% over the past year. Earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 16 Apr 2025DKK 2.3tDKK 409.3bDKK 121.3b22x19.3x5.7x
Fri, 14 Mar 2025DKK 2.8tDKK 409.5bDKK 121.3b24.7x23.3x6.9x
Sun, 09 Feb 2025DKK 3.3tDKK 408.3bDKK 118.3b28.7x28.1x8.2x
Tue, 07 Jan 2025DKK 3.3tDKK 387.4bDKK 111.3b29.7x29.5x8.5x
Thu, 05 Dec 2024DKK 4.0tDKK 387.3bDKK 111.3b31.6x36.1x10.4x
Sat, 02 Nov 2024DKK 4.0tDKK 372.2bDKK 107.2b34.5x37.1x10.7x
Mon, 30 Sep 2024DKK 4.1tDKK 371.9bDKK 107.1b36.5x38.4x11.1x
Wed, 28 Aug 2024DKK 4.6tDKK 371.7bDKK 107.1b33.1x43.3x12.5x
Fri, 26 Jul 2024DKK 4.5tDKK 355.4bDKK 106.3b35.7x42.4x12.7x
Sun, 23 Jun 2024DKK 4.9tDKK 355.4bDKK 106.2b34.5x46.6x13.9x
Tue, 21 May 2024DKK 4.6tDKK 355.3bDKK 106.2b37.8x43.2x12.9x
Thu, 18 Apr 2024DKK 4.5tDKK 341.3bDKK 99.6b33.9x44.7x13x
Sat, 16 Mar 2024DKK 4.6tDKK 341.2bDKK 99.6b39.3x46.5x13.6x
Mon, 12 Feb 2024DKK 4.3tDKK 340.5bDKK 98.6b33.1x43.3x12.6x
Wed, 10 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b34.1x41.7x11.7x
Fri, 08 Dec 2023DKK 3.5tDKK 320.5bDKK 90.0b33.1x38.7x10.9x
Sun, 05 Nov 2023DKK 3.5tDKK 318.7bDKK 90.3b29.1x39.2x11.1x
Tue, 03 Oct 2023DKK 3.4tDKK 305.6bDKK 82.2b32.8x41.4x11.1x
Thu, 31 Aug 2023DKK 3.4tDKK 305.2bDKK 82.1b35.9x41.6x11.2x
Sat, 29 Jul 2023DKK 2.9tDKK 287.1bDKK 75.5b37.2x38.5x10.1x
Mon, 26 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b39.9x39.7x10.4x
Wed, 24 May 2023DKK 3.1tDKK 287.1bDKK 75.5b41.9x41.7x10.9x
Fri, 21 Apr 2023DKK 3.1tDKK 272.6bDKK 68.5b43.6x45.1x11.3x
Sun, 19 Mar 2023DKK 2.7tDKK 292.6bDKK 69.2b37.6x39.6x9.4x
Tue, 14 Feb 2023DKK 2.8tDKK 289.4bDKK 68.9b40.2x40.5x9.6x
Thu, 12 Jan 2023DKK 2.6tDKK 276.0bDKK 66.3b37.7x39.4x9.5x
Sat, 10 Dec 2022DKK 2.7tDKK 276.1bDKK 66.3b38.5x40.2x9.7x
Mon, 07 Nov 2022DKK 2.5tDKK 271.2bDKK 64.6b36x38x9.1x
Wed, 05 Oct 2022DKK 2.3tDKK 261.2bDKK 62.4b35.2x36.9x8.8x
Fri, 02 Sep 2022DKK 2.3tDKK 260.4bDKK 62.4b34.7x36.8x8.8x
Sun, 31 Jul 2022DKK 2.5tDKK 247.8bDKK 59.9b38x42.2x10.2x
Tue, 28 Jun 2022DKK 2.4tDKK 247.6bDKK 59.9b36.6x39.4x9.5x
Thu, 26 May 2022DKK 2.2tDKK 247.6bDKK 59.7b34x37.1x8.9x
Sat, 23 Apr 2022DKK 2.4tDKK 238.1bDKK 59.8b38.1x39.7x10x
Price to Earnings Ratio

39.7x


Total Market Cap: DKK 2.4tTotal Earnings: DKK 59.8bTotal Revenue: DKK 238.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 39.3x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 19.3x which is lower than its 3-year average PE of 39.3x.
  • The 3-year average PS ratio of 10.6x is higher than the industry's current PS ratio of 5.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 27% per year over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market1.51%
Healthcare-1.33%
Healthcare Services4.63%
Life Sciences3.66%
Biotech1.60%
Medical Equipment1.29%
Pharma-1.87%
Healthtech-2.15%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 100x.
    • Analysts expect its future annual earnings growth (16.1%) to be largely in line with prior year's earnings growth.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 61% over the next 5 years.
  • This is better than its past earnings decline of 83% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 3.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
COLO B ColoplastDKK 702.201.2%
+DKK 1.9b		-23.3%PE32.4x
GMAB GenmabDKK 1.29k1.9%
+DKK 1.6b		-37.2%PE10.5x
DEMANT DemantDKK 227.402.1%
+DKK 979.9m		-28.4%PE16.8x
CHEMM ChemoMetecDKK 490.8011.7%
+DKK 894.5m		58.8%PE50.5x
ALK B ALK-AbellóDKK 146.602.7%
+DKK 840.5m		15.2%PE39.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALK B

DKK 146.60

ALK-Abelló

7D

2.7%

1Y

15.2%

Here's Why ALK-Abelló (CPH:ALK B) Has Caught The Eye Of Investors

Apr 16
Here's Why ALK-Abelló (CPH:ALK B) Has Caught The Eye Of Investors

NOVO B

DKK 425.65

Novo Nordisk

7D

-1.9%

1Y

-50.9%

author-image

EU#2 - From Humble Beginnings to Global Powerhouse

Apr 15CagriSema – a combination therapy for obesity and diabetes that may be even more effective than Wegovy.

HLUN B

DKK 28.80

H. Lundbeck

7D

-2.4%

1Y

-12.7%

Why Investors Shouldn't Be Surprised By H. Lundbeck A/S' (CPH:HLUN B) 29% Share Price Plunge

Apr 13
Why Investors Shouldn't Be Surprised By H. Lundbeck A/S' (CPH:HLUN B) 29% Share Price Plunge

BAVA

DKK 151.00

Bavarian Nordic

7D

2.1%

1Y

-0.8%

PEG

DKK 0.085

Pharma Equity Group

7D

-22.3%

1Y

-70.8%

We Think Pharma Equity Group (CPH:PEG) Has A Fair Chunk Of Debt

Apr 08
We Think Pharma Equity Group (CPH:PEG) Has A Fair Chunk Of Debt

CHEMM

DKK 490.80

ChemoMetec

7D

11.7%

1Y

58.8%

Getting In Cheap On ChemoMetec A/S (CPH:CHEMM) Is Unlikely

Apr 06
Getting In Cheap On ChemoMetec A/S (CPH:CHEMM) Is Unlikely

DEMANT

DKK 227.40

Demant

7D

2.1%

1Y

-28.4%

Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly

Apr 04
Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly

GUBRA

DKK 372.00

Gubra

7D

-5.9%

1Y

33.3%

BRAINP

DKK 0.019

Brain+

7D

-67.2%

1Y

-85.7%

GMAB

DKK 1,293.00

Genmab

7D

1.9%

1Y

-37.2%

VIRO

DKK 6.50

ViroGates

7D

-7.1%

1Y

8.3%

ZEAL

DKK 445.00

Zealand Pharma

7D

0.4%

1Y

-26.4%

Most Shareholders Will Probably Find That The CEO Compensation For Zealand Pharma A/S (CPH:ZEAL) Is Reasonable

Mar 21
Most Shareholders Will Probably Find That The CEO Compensation For Zealand Pharma A/S (CPH:ZEAL) Is Reasonable

AMBU B

DKK 117.90

Ambu

7D

0.9%

1Y

5.5%

Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

Mar 14
Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

NNIT

DKK 66.60

NNIT

7D

-1.9%

1Y

-39.0%

COLO B

DKK 702.20

Coloplast

7D

1.2%

1Y

-23.3%